Company intelligence / Profile preview

Avant Technologies

Las Vegas, Nevada, United States

Ownership: Private
Development stage: Other

Overview

Avant, in partnership with Ainnova Tech, has advanced the Vision AI platform (retinal camera + AI analysis) to FDA-bound clinical studies for early diabetic retinopathy detection and multi-disease risk analysis, with robust real-world clinical data being gathered via a multi-center US clinical trial targeting diverse diabetic patients[5][6][8].

Therapeutic areas: EndocrinologyNephrologyOphthalmologyGastroenterologyCardiovascularOncologyNeurology
Modalities: DeviceArtificial intelligence software
Industry: Medical Imaging

Partnerships

Ainnova Tech (technology, device, and AI)Fortrea (CRO for ophthalmology/device trials)Grupo Dökka (deployment of Vision AI in pharmacy chains)Fischel and La Bomba pharmacies (end-user pilot sites)

Beyond the preview

Go deeper on Avant Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Avant Technologies.

Explore the full profile